Prescription Drug Monitoring Programs and Buprenorphine Maintenance: Clinical Considerations

被引:1
|
作者
Hoefer, Michael [1 ]
Petrakis, Ismene [1 ]
机构
[1] Yale Univ, Sch Med, West Haven, CT 06405 USA
来源
AMERICAN JOURNAL ON ADDICTIONS | 2014年 / 23卷 / 06期
关键词
D O I
10.1111/j.1521-0391.2014.12149.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:616 / 617
页数:2
相关论文
共 50 条
  • [21] Research to support optimization of prescription drug monitoring programs
    Doyle, Sheri
    Leichtling, Gillian
    Hildebran, Christi
    Reilly, Cynthia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 (11) : 1425 - 1427
  • [22] Prescription Drug Monitoring Programs and Opioid Death Rates
    Rudman, William, Jr.
    Corcoran, Peter
    Elliot, Kimberly
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (20): : 2044 - 2044
  • [23] Community Pharmacist Involvement in Prescription Drug Monitoring Programs
    Doong, Katie S.
    Gaccione, Daniella M.
    Brown, Todd A.
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2016, 8 (06) : 227 - 229
  • [24] EFFECT OF PRESCRIPTION DRUG MONITORING PROGRAMS ON TESTOSTERONE PRESCRIPTIONS
    Mulloy, E.
    Eisenberg, M.
    Li, S.
    JOURNAL OF SEXUAL MEDICINE, 2022, 19 (04): : S122 - S122
  • [25] Prescription drug monitoring programs, opioid abuse, and crime
    Dave, Dhaval
    Deza, Monica
    Horn, Brady
    SOUTHERN ECONOMIC JOURNAL, 2021, 87 (03) : 808 - 848
  • [26] Perceived Unintended Consequences of Prescription Drug Monitoring Programs
    Lai, Alden Yuanhong
    Smith, Katherine C.
    Vernick, Jon S.
    Davis, Corey S.
    Alexander, G. Caleb
    Rutkow, Lainie
    SUBSTANCE USE & MISUSE, 2019, 54 (02) : 345 - 349
  • [27] Prescription Drug Monitoring Programs and Death Rates from Drug Overdose
    Paulozzi, Leonard J.
    Kilbourne, Edwin M.
    Desai, Hema A.
    PAIN MEDICINE, 2011, 12 (05) : 747 - 754
  • [28] Prescription drug monitoring programs use mandates and prescription stimulant and depressant quantities
    Gunadi, Christian
    Shi, Yuyan
    BMC PUBLIC HEALTH, 2023, 23 (01)
  • [29] Do prescription drug monitoring programs encourage prescription - or illicit - opioid abuse?
    Meadowcroft, Devon
    Whitacre, Brian
    SUBSTANCE ABUSE, 2021, 42 (01) : 65 - 75
  • [30] Prescription drug monitoring programs use mandates and prescription stimulant and depressant quantities
    Christian Gunadi
    Yuyan Shi
    BMC Public Health, 23